Functional interaction between cyclooxygenase-2 and p53 in response to an endogenous electrophile

Redox Biology

Volumn 4, Issue , 2015, Pages 74-86

  Kumagai, Takeshi ^a   Usami, Hiroko ^a   Matsukawa, Nao ^a   Nakashima, Fumie ^a   Chikazawa, Miho ^a   Shibata, Takahiro ^a   Noguchi, Noriko ^b   Uchida, Koji ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b DOSHISHA UNIVERSITY   (Japan)

Author keywords

4 Hydroxy 2 nonenal; Cyclooxygenase; Lipid peroxidation; P53; Proteasome; Sp1

Indexed keywords

4 HYDROXYNONENAL; COMPLEMENTARY DNA; CYCLOOXYGENASE 2; ELECTROPHILE; PROTEASOME; PROTEIN P53; TRANSCRIPTION FACTOR SP1; 4-HYDROXY-2-NONENAL; ALDEHYDE; ARACHIDONIC ACID; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PROSTAGLANDIN;

ANIMAL CELL; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; CYCLOOXYGENASE 2 GENE; DNA SEQUENCE; DOWN REGULATION; ELECTROPHILICITY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME STABILITY; ENZYME SYNTHESIS; GENE EXPRESSION; INTRACELLULAR SIGNALING; LIPID PEROXIDATION; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; SENSITIVITY ANALYSIS; UBIQUITINATION; UPREGULATION; ANIMAL; BIOSYNTHESIS; CELL LINE; DNA MICROARRAY; DRUG EFFECTS; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; SIGNAL TRANSDUCTION;

RATTUS;

ALDEHYDES; ANIMALS; ARACHIDONIC ACID; CELL LINE; CYCLOOXYGENASE 2; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; LIPID PEROXIDATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROSTAGLANDINS; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84917707347     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2014.11.011     Document Type: Article

References (81)

1. Smith W.L., Garavito R.M., DeWitt D.L. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. Journal of Biological Chemistry 1996, 271(52):33157-33160. http://www.ncbi.nlm.nih.gov/pubmed/8969167, 10.1074/jbc.271.52.33157.
2. Yamamoto K., Arakawa T., Ueda N., Yamamoto S. Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. Journal of Biological Chemistry 1995, 270(52):31315-31320. http://www.ncbi.nlm.nih.gov/pubmed/8537402.
3. Ryseck R.P., Raynoschek C., Macdonald-Bravo H., Dorfman K., Mattéi M.G., Bravo R. Identification of an immediate early gene, pghs-B, whose protein product has prostaglandin synthase/cyclooxygenase activity. Cell Growth & Dfferentiation 1992, 3(7):443-450. http://www.ncbi.nlm.nih.gov/pubmed/1419907.
4. Yamagata K., Andreasson K.I., Kaufmann W.E., Barnes C.A., Worley P.F. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 1993, 11(2):371-386. http://www.ncbi.nlm.nih.gov/pubmed/8352945, 10.1016/0896-6273(93)90192-T.
5. Newton R., Seybold J., Kuitert L.M., Bergmann M., Barnes P.J. Repression of cyclooxygenase-2 and prostaglandin E2 release by dexamethasone occurs by transcriptional and post-transcriptional mechanisms involving loss of polyadenylated mRNA. Journal of Biological Chemistry 1998, 273(48):32312-32321. http://www.ncbi.nlm.nih.gov/pubmed/9822711, 10.1074/jbc.273.48.32312.
6. Dean J.L., Brook M., Clark A.R., Saklatvala J. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. Journal of Biological Chemistry 1999, 274(1):264-269. http://www.ncbi.nlm.nih.gov/pubmed/9867839, 10.1074/jbc.274.1.264.
7. Subbaramaiah K., Altorki N., Chung W.J., Mestre J.R., Sampat A., Dannenberg A.J. Inhibition of cyclooxygenase-2 gene expression by p53. Journal of Biological Chemistry 1999, 274(16):10911-10915. http://www.ncbi.nlm.nih.gov/pubmed/10196169, 10.1074/jbc.274.16.10911.
8. Chandrasekharan N.V., Dai H., Roos K.L., Evanson N.K., Tomsik J., Elton T.S., Simmons D.L. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:13926-13931. http://www.ncbi.nlm.nih.gov/pubmed/12242329, 10.1073/pnas.162468699.
9. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell 1997, 88(3):323-331. http://www.ncbi.nlm.nih.gov/pubmed/9039259, 10.1016/S0092-8674(00)81871-1.
10. Hansen R., Oren M. p53; from inductive signal to cellular effect. Current Opinion in Genetics & Development 1997, 7(1):46-51. http://www.ncbi.nlm.nih.gov/pubmed/9024633, 10.1016/S0959-437X(97)80108-6.
11. Agarwal M.L., Taylor W.R., Chernov M.V., Chernova O.B., Stark G.R. The p53 network. Journal of Biological Chemistry 1998, 273(1):1-4. http://www.ncbi.nlm.nih.gov/pubmed/9417035, 10.1074/jbc.273.1.1.
12. Oren M. Regulation of the p53 tumor suppressor protein. Journal of Biological Chemistry 1999, 274(51):36031-36034. http://www.ncbi.nlm.nih.gov/pubmed/10593882, 10.1074/jbc.274.51.36031.
13. El-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993, 75(4):817-825. http://www.ncbi.nlm.nih.gov/pubmed/8242752, 10.1016/0092-8674(93)90500-P.
14. Barak Y., Juven T., Haffner R., Oren M. mdm2 expression is induced by wild type p53 activity. EMBO Journal 1993, 12(2):461-468. http://www.ncbi.nlm.nih.gov/pubmed/8440237.
15. Miyashita T., Krajewski S., Krajewska M., Wang H.G., Lin H.K., Liebermann D.A., Hoffman B., Reed J.C. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994, 9(6):1799-1805. http://www.ncbi.nlm.nih.gov/pubmed/8183579.
16. Miyashita T., Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995, 80(2):293-299. http://www.ncbi.nlm.nih.gov/pubmed/7834749, 10.1016/0092-8674(95)90412-3.
17. Wang Q., Zambetti G.P., Suttle D.P. Inhibition of DNA topoisomerase II alpha gene expression by the p53 tumor suppressor. Molecular and Cellular Biology 1997, 17(1):389-397. http://www.ncbi.nlm.nih.gov/pubmed/8972219.
18. Wang Q., Beck W.T. Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53. Cancer Research 1998, 58(24):5762-5769. http://www.ncbi.nlm.nih.gov/pubmed/9865734.
19. Ding B.C., Whetstine J.R., Witt T.L., Schuetz J.D., Matherly L.H. Repression of human reduced folate carrier gene expression by wild type p53. Journal of Biological Chemistry 2001, 276(12):8713-8719. http://www.ncbi.nlm.nih.gov/pubmed/11106643, 10.1074/jbc.M005248200.
20. Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine 1989, Clarendon Press, Oxford. second edition.
21. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biology and Medicine 1991, 11(1):81-128. http://www.ncbi.nlm.nih.gov/pubmed/1937131.
22. Uchida K. Role of reactive aldehyde in cardiovascular diseases. Free Radical Biology and Medicine 2000, 28(12):1685-1696. http://www.ncbi.nlm.nih.gov/pubmed/10946210.
23. Nanji A.A., Miao L., Thomas P., Rahemtulla A., Khwaja S., Zhao S., Peters D., Tahan S.R., Dannenberg A.J. Enhanced cyclooxygenase-2 gene expression in alcoholic liver disease in the rat. Gastroenterology 1997, 112(3):943-951. http://www.ncbi.nlm.nih.gov/pubmed/9041257.
24. Kumagai T., Kawamoto Y., Nakamura Y., Hatayama I., Satoh K., Osawa T., Uchida K. 4-Hydroxy-2-nonenal, the end product of lipid peroxidation, is a specific inducer of cyclooxygenase-2 gene expression. Biochemical and Biophysical Research Communications 2000, 273(2):437-441. http://www.ncbi.nlm.nih.gov/pubmed/10873624, 10.1006/bbrc.2000.2967.
25. Kumagai T., Nakamura Y., Osawa T., Uchida K. Role of p38 mitogen-activated protein kinase in the 4-hydroxy-2-nonenal-induced cyclooxygenase-2 expression. Archives of Biochemistry and Biophysics 2002, 397(2):240-245. http://www.ncbi.nlm.nih.gov/pubmed/11795877, 10.1006/abbi.2001.2601.
26. Brown P.O., Botstein D. Exploring the new world of the genome with DNA microarrays. Nature Genetics 1999, 21(1 Suppl.):33-37. http://www.ncbi.nlm.nih.gov/pubmed/9915498, 10.1038/4462.
27. Kondo M., Oya-Ito T., Kumagai T., Osawa T., Uchida K. Cyclopentenone prostaglandins as potential inducers of intracellular oxidative stress. Journal of Biological Chemistry 2001, 276(15):12076-12083. http://www.ncbi.nlm.nih.gov/pubmed/11278531, 10.1074/jbc.M009630200.
28. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227(5259):680-685. http://www.ncbi.nlm.nih.gov/pubmed/5432063.
29. Ohlsson C., Kley N., Werner H., LeRoith D. p53 regulates insulin-like growth factor-I (IGF-I) receptor expression and IGF-I-induced tyrosine phosphorylation in an osteosarcoma cell line: interaction between p53 and Sp1. Endocrinology 1998, 139(3):1101-1107. http://www.ncbi.nlm.nih.gov/pubmed/9492043, 10.1210/endo.139.3.5832.
30. Appleby S.B., Ristimäki A., Neilson K., Narko K., Hla T. Structure of the human cyclo-oxygenase-2 gene. Biochemical Journal 1994, 302(3):723-727. http://www.ncbi.nlm.nih.gov/pubmed/7945196.
31. Li B., Lee M.Y. Transcriptional regulation of the human DNA polymerase delta catalytic subunit gene POLD1 by p53 tumor suppressor and Sp1. Journal of Biological Chemistry 2001, 276(32):29729-29739. http://www.ncbi.nlm.nih.gov/pubmed/11375983, 10.1074/jbc.M101167200.
32. Koutsodontis G., Tentes I., Papakosta P., Moustakas A., Kardassis D. Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by the p53 tumor suppressor protein. Journal of Biological Chemistry 2001, 276(31):29116-29125. http://www.ncbi.nlm.nih.gov/pubmed/11384995, 10.1074/jbc.M104130200.
33. Thornborrow E.C., Manfredi J.J. The tumor suppressor protein p53 requires a cofactor to activate transcriptionally the human BAX promoter. Journal of Biological Chemistry 2001, 276(19):15598-15608. http://www.ncbi.nlm.nih.gov/pubmed/11278953, 10.1074/jbc.M011643200.
34. Black A.R., Jensen D., Lin S.Y., Azizkhan J.C. Growth/cell cycle regulation of Sp1 phosphorylation. Journal of Biological Chemistry 1999, 274(3):1207-1215. http://www.ncbi.nlm.nih.gov/pubmed/9880488.
35. Schmedtje J.F., Ji Y.-S., Liu W.-L., DuBois R.N., Runge M.S. Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. Journal of Biological Chemistry 1997, 272(1):601-608. http://www.ncbi.nlm.nih.gov/pubmed/8995303.
36. Ciechanover A. The ubiquitin-proteasome proteolytic pathway. Cell 1994, 79(1):13-21. http://www.ncbi.nlm.nih.gov/pubmed/7923371.
37. Hochstrasser M. Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Current Opinion in Cell Biology 1995, 7(2):215-223. http://www.ncbi.nlm.nih.gov/pubmed/7612274.
38. Jentsch S., Schlenker S. Selective protein degradation: a journey's end within the proteasome. Cell 1995, 82(6):881-884. http://www.ncbi.nlm.nih.gov/pubmed/7553848.
39. Uchida K. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Progress in Lipid Research 2003, 42(4):318-343. http://www.ncbi.nlm.nih.gov/pubmed/12689622.
40. Schönbeck U., Sukhova G.K., Graber P., Coulter S., Libby P. Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions. American Journal of Pathology 1999, 155(4):1281-1291. http://www.ncbi.nlm.nih.gov/pubmed/10514410, 10.1016/S0002-9440(10)65230-3.
41. Ho L., Pieroni C., Winger D., Purohit D.P., Aisen P.S., Pasinetti G.M. Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's disease. Journal of Neuroscience Research 1999, 57(3):295-303. http://www.ncbi.nlm.nih.gov/pubmed/10412020.
42. Meagher E.A., Barry O.P., Burke A., Lucey M.R., Lawson J.A., Rokach J., FitzGerald G.A. Alcohol-induced generation of lipid peroxidation products in humans. Journal of Clinical Investigation 1999, 104(6):805-813. http://www.ncbi.nlm.nih.gov/pubmed/10491416, 10.1172/JCI5584.
43. Li C.J., Nanji A.A., Siakotos A.N., Lin R.C. Acetaldehyde-modified and 4-hydroxynonenal-modified proteins in the livers of rats with alcoholic liver disease. Hepatology 1997, 26(3):650-657. http://www.ncbi.nlm.nih.gov/pubmed/9303495, 10.1002/hep.510260317.
44. DuBois R.N., Awad J., Morrow J., Roberts L.J., Bishop P.R. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester. Journal of Clinical Investigation 1994, 93(2):493-498. http://www.ncbi.nlm.nih.gov/pubmed/8113389, 10.1172/JCI116998.
45. Misko T.P., Trotter J.L., Cross A.H. Mediation of inflammation by encephalitogenic cells: interferon gamma induction of nitric oxide synthase and cyclooxygenase 2. Journal of Neuroimmunology 1995, 61(2):195-204. http://www.ncbi.nlm.nih.gov/pubmed/7593555, 10.1016/0165-5728(95)00091-F.
46. Chen Q.R., Miyaura C., Higashi S., Murakami M., Kudo I., Saito S., Hiraide T., Shibasaki Y., Suda T. Activation of cytosolic phospholipase A2 by platelet-derived growth factor is essential for cyclooxygenase-2-dependent prostaglandin E2 synthesis in mouse osteoblasts cultured with interleukin-1. Journal of Biological Chemistry 1997, 272(9):5952-5958. http://www.ncbi.nlm.nih.gov/pubmed/9038215, 10.1074/jbc.272.9.5952.
47. Perkins D.J., Kniss D.A. Rapid and transient induction of cyclo-oxygenase 2 by epidermal growth factor in human amnion-derived WISH cells. Biochemical Journal 1997, 321(3):677-681. http://www.ncbi.nlm.nih.gov/pubmed/9032453.
48. Adderley S.R., Fitzgerald D.J. Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2. Journal of Biological Chemistry 1999, 274(8):5038-5046. http://www.ncbi.nlm.nih.gov/pubmed/9988750, 10.1074/jbc.274.8.5038.
49. Shinmura K., Tang X.L., Wang Y., Xuan Y.T., Liu S.Q., Takano H., Bhatnagar A., Bolli R. Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits. Proceedings of the National Academy of Sciences of the United States of America 2000, 97(18):10197-10202. http://www.ncbi.nlm.nih.gov/pubmed/10963682, 10.1073/pnas.97.18.10197.
50. Steinauer K.K., Gibbs I., Ning S., French J.N., Armstrong J., Knox S.J. Radiation induces upregulation of cyclooxygenase-2 (COX-2) protein in PC-3 cells. International Journal of Radiation Oncology-Biology-Physics 2000, 48(2):325-328. http://www.ncbi.nlm.nih.gov/pubmed/10974444, 10.1016/S0360-3016(00)00671-4.
51. Kargman S.L., O'Neill G.P., Vickers P.J., Evans J.F., Mancini J.A., Jothy S. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Research 1995, 55(12):2556-2559. http://www.ncbi.nlm.nih.gov/pubmed/7780968.
52. Sano H., Kawahito Y., Wilder R.L., Hashiramoto A., Mukai S., Asai K., Kimura S., Kato H., Kondo M., Hla T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Research 1995, 55(17):3785-3789. http://www.ncbi.nlm.nih.gov/pubmed/7641194.
53. Ristimäki A., Honkanen N., Jänkälä H., Sipponen P., Härkönen M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Research 1997, 57(7):1276-1280. http://www.ncbi.nlm.nih.gov/pubmed/9102213.
54. Müller-Decker K., Scholz K., Marks F., Fürstenberger G. Differential expression of prostaglandin H synthase isozymes during multistage carcinogenesis in mouse epidermis. Molecular Carcinogenesis 1995, 12(1):31-41. http://www.ncbi.nlm.nih.gov/pubmed/7818763, 10.1002/mc.2940120106.
55. Parrett M., Harris R., Joarder F., Ross M., Clausen K., Robertson F. Cyclooxygenase-2 gene expression in human breast cancer. International Journal of Oncology 1997, 10(3):503-507. http://www.ncbi.nlm.nih.gov/pubmed/21533404, 10.3892/ijo.10.3.503.
56. Santhanam U., Ray A., Sehgal P.B. Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product. Proceedings of the National Academy of Sciences of the United States of America 1991, 88(17):7605-7609. http://www.ncbi.nlm.nih.gov/pubmed/1652755, 10.1073/pnas.88.17.7605.
57. Seto E., Usheva A., Zambetti G.P., Momand J., Horikoshi N., Weinmann R., Levine A.J., Shenk T. Wild-type p53 binds to the TATA-binding protein and represses transcription. Proceedings of the National Academy of Sciences of the United States of America 1992, 89(24):12028-12032. http://www.ncbi.nlm.nih.gov/pubmed/1465435, 10.1073/pnas.89.24.12028.
58. Mack D.H., Vartikar J., Pipas J.M., Laimins L.A. Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53. Nature 1993, 363(6426):281-283. http://www.ncbi.nlm.nih.gov/pubmed/8387645, 10.1038/363281a0.
59. Kong X., Peng B., Yang Y., Zhang P., Qin B., Han D., Wang C., Dang Y., Liu J.O., Yu L. p53 represses transcription of RING finger LIM domain-binding protein RLIM through Sp1. PLOS One 2013, 8(5):e62832. http://www.ncbi.nlm.nih.gov/pubmed/23650532, 10.1371/journal.pone.0062832.
60. Xu Q., Ji Y.S., Schmedtje J.F. Sp1 increases expression of cyclooxygenase-2 in hypoxic vascular endothelium. Implications for the mechanisms of aortic aneurysm and heart failure. Journal of Biological Chemistry 2000, 275(32):24583-24589. http://www.ncbi.nlm.nih.gov/pubmed/10825178, 10.1074/jbc.M003894200.
61. Dhar S.K., Xu Y., Chen Y., St Clair D.K. Specificity protein 1-dependent p53-mediated suppression of human manganese superoxide dismutase gene expression. Journal of Biological Chemistry 2006, 281(31):21698-21709. http://www.ncbi.nlm.nih.gov/pubmed/16740634, 10.1074/jbc.M601083200.
62. Cai B.H., Hsu P.C., Hsin I.L., Chao C.F., Lu M.H., Lin H.C., Chiou S.H., Tao P.L., Chen J.Y. p53 acts as a co-repressor to regulate keratin 14 expression during epidermal cell differentiation. PLOS One 2012, 7(7):e41742. http://www.ncbi.nlm.nih.gov/pubmed/22911849, 10.1371/journal.pone.0041742.
63. Gottlieb T.M., Leal J.F., Seger R., Taya Y., Oren M. Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis. Oncogene 2002, 21(8):1299-1303. http://www.ncbi.nlm.nih.gov/pubmed/11850850, 10.1038/sj.onc.1205181.
64. Mayo L.D., Donner D.B. A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proceedings of the National Academy of Sciences of the United States of America 2001, 98(20):11598-11603. http://www.ncbi.nlm.nih.gov/pubmed/11504915, 10.1073/pnas.181181198.
65. Ogawara Y., Kishishita S., Obata T., Isazawa Y., Suzuki T., Tanaka K., Masuyama N., Gotoh Y. Akt enhances Mdm2-mediated ubiquitination and degradation of p53. Journal of Biological Chemistry 2002, 277(24):21843-21850. http://www.ncbi.nlm.nih.gov/pubmed/11923280, 10.1074/jbc.M109745200.
66. Lee S.J., Seo K.W., Yun M.R., Bae S.S., Lee W.S., Hong K.W., Kim C.D. 4-hydroxynonenal enhances MMP-2 production in vascular smooth muscle cells via mitochondrial ROS-mediated activation of the Akt/NF-kappaB signaling pathways. Free Radical Biology and Medicine 2008, 45(10):1487-1492. http://www.ncbi.nlm.nih.gov/pubmed/18805481, 10.1016/j.freeradbiomed.2008.08.022.
67. Prescott S.M., Fitzpatrick F.A. Cyclooxygenase-2 and carcinogenesis. Biochimica et Biophysica Acta 2000, 1470(2):M69-M78. http://www.ncbi.nlm.nih.gov/pubmed/10722929, 10.1016/S0304-419X(00)00006-8.
68. Tsujii M., Dubois R.N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995, 83(3):493-501. http://www.ncbi.nlm.nih.gov/pubmed/8521479, 10.1016/0092-8674(95)90127-2.
69. Tsujii M., Kawano S., Tsuji S., Sawaoka H., Hori M., Dubois R.N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998, 93(5):705-716. http://www.ncbi.nlm.nih.gov/pubmed/9630216, 10.1016/S0092-8674(02)09420-5.
70. Trifan O.C., Smith R.M., Thompson B.D., Hla T. Overexpression of cyclooxygenase-2 induces cell cycle arrest. Evidence for a prostaglandin-independent mechanism. Journal of Biological Chemistry 1999, 274(48):34141-34147. http://www.ncbi.nlm.nih.gov/pubmed/10567385, 10.1074/jbc.274.48.34141.
71. Ristimäki A., Garfinkel S., Wessendorf J., Maciag T., Hla T. Induction of cyclooxygenase-2 by interleukin-1alpha. Evidence for post-transcriptional regulation. Journal of Biological Chemistry 1994, 269(16):11769-11775. http://www.ncbi.nlm.nih.gov/pubmed/8163473.
72. Tanaka K. Proteasomes: structure and biology. Journal of Biochemistry 1998, 123(2):195-204. 10.1093/oxfordjournals.jbchem.a021922.
73. Tanaka K., Chiba T. The proteasome: a protein-destroying machine. Genes Cells 1998, 3(8):499-510. http://www.ncbi.nlm.nih.gov/pubmed/9797452, 10.1046/j.1365-2443.1998.00207.x.
74. Tanahashi N., Kawahara H., Murakami Y., Tanaka K. The proteasome-dependent proteolytic system. Molecular Biology Reports 1999, 26(1-2):3-9. http://www.ncbi.nlm.nih.gov/pubmed/10363639, 10.1023/A:1006909522731.
75. Ding Q., Keller J.N. Proteasomes and proteasome inhibition in the central nervous system. Free Radical Biology and Medicine 2001, 31(5):574-584. http://www.ncbi.nlm.nih.gov/pubmed/11522442.
76. Halliwell B. Hypothesis: proteasomal dysfunction: a primary event in neurogeneration that leads to nitrative and oxidative stress and subsequent cell death. Annals of the New York Academy 2002, 962:182-194. http://www.ncbi.nlm.nih.gov/pubmed/12076974, 10.1111/j.1749-6632.2002.tb04067.x.
77. Jenner P. Oxidative stress in Parkinson's disease. Annals of Neurology 2003, 53:S26-S38. 10.1002/ana.10483.
78. Praticò D., Delanty N. Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease. American Journal of Medicine 2000, 109(7):577-585. http://www.ncbi.nlm.nih.gov/pubmed/11063960, 10.1016/S0002-9343(00)00547-7.
79. 2 on proteasome. Biochemistry 2003, 42(47):13960-13968. http://www.ncbi.nlm.nih.gov/pubmed/14636064, 10.1021/bi035215a.
80. Aki M., Tamura T., Tokunaga F., Iwanaga S., Kawamura Y., Shimbara N., Kagawa S., Tanaka K., Ichihara A. cDNA cloning of rat proteasome subunit RC1, a homologue of RING10 located in the human MHC class II region. FEBS Letters 1992, 301(1):65-68. http://www.ncbi.nlm.nih.gov/pubmed/1451788, 10.1016/0014-5793(92)80211-X.
81. Ballif B.A., Mincek N.V., Barratt J.T., Wilson M.L., Simmons D.L. Interaction of cyclooxygenases with an apoptosis- and autoimmunity-associated protein. Proceedings of the National Academy of Sciences of the United States of America 1996, 93(11):5544-5549. http://www.ncbi.nlm.nih.gov/pubmed/8643612, 10.1073/pnas.93.11.5544.